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Roles for PI(3,5)P2 in nutrient sensing through 
TORC1
Natsuko Jina, Kai Maoa,b, Yui Jina, Gela Tevzadzec, Emily J. Kauffmana, Sujin Parka,*, 
Dave Bridgesd,†, Robbie Loewithc, Alan R. Saltield, Daniel J. Klionskya,b, and Lois S. Weismana,e
aLife Sciences Institute, bDepartment of Molecular, Cellular, and Developmental Biology and Department of Biological 
Chemistry, and dDepartment of Internal Medicine and Molecular and Integrative Physiology, University of Michigan, 
Ann Arbor, MI 48109; cDepartment of Molecular Biology, University of Geneva, Geneva 1211, Switzerland; 
eDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109 
ABSTRACT TORC1, a conserved protein kinase, regulates cell growth in response to nutri-
ents. Localization of mammalian TORC1 to lysosomes is essential for TORC1 activation. Phos-
phatidylinositol 3,5-bisphosphate (PI(3,5)P2), an endosomal signaling lipid, is implicated in 
insulin-dependent stimulation of TORC1 activity in adipocytes. This raises the question of 
whether PI(3,5)P2 is an essential general regulator of TORC1. Moreover, the subcellular loca-
tion where PI(3,5)P2 regulates TORC1 was not known. Here we report that PI(3,5)P2 is re-
quired for TORC1 activity in yeast and regulates TORC1 on the vacuole (lysosome). Further-
more, we show that the TORC1 substrate, Sch9 (a homologue of mammalian S6K), is 
recruited to the vacuole by direct interaction with PI(3,5)P2, where it is phosphorylated by 
TORC1. Of importance, we find that PI(3,5)P2 is required for multiple downstream pathways 
via TORC1-dependent phosphorylation of additional targets, including Atg13, the modifica-
tion of which inhibits autophagy, and phosphorylation of Npr1, which releases its inhibitory 
function and allows nutrient-dependent endocytosis. These findings reveal PI(3,5)P2 as a gen-
eral regulator of TORC1 and suggest that PI(3,5)P2 provides a platform for TORC1 signaling 
from lysosomes.
INTRODUCTION
The mechanistic target of rapamycin (mTOR) is an evolutionarily 
conserved protein kinase that is critical for homeostatic control 
of cell growth and metabolism (reviewed in Kim and Guan, 
2009; Laplante and Sabatini, 2009; Loewith and Hall, 2011). 
mTOR functions within two distinct complexes, TORC1 and 
TORC2 (Loewith et al., 2002). Although most organisms have a 
single TOR gene, some yeast, including Saccharomyces cerevi-
siae, have two, TOR1 and TOR2. In yeast, TORC1 consists of 
four proteins: Tor1 or Tor2, Kog1 (homologue of Raptor), Lst8 
(homologue of mLST8/GβL), and Tco89. TORC1 responds to nu-
tritional status and positively regulates protein synthesis and 
cell growth while negatively regulating autophagy (reviewed in 
Loewith and Hall, 2011).
TORC1 resides predominantly on the vacuole membrane in 
yeast (Reinke et al., 2004; Araki et al., 2005; Urban et al., 2007; 
Sturgill et al., 2008; Binda et al., 2009). The localization and activity 
of TORC1 on the vacuole is critical for yeast viability. Moreover, 
several vacuole-related mutants are synthetically lethal with the 
tor1Δ mutant, which retains some TORC1 function (Zurita-Martinez 
et al., 2007). Mammalian TORC1 is recruited to late endosomes 
and lysosomes in response to the presence of amino acids (Sancak 
et al., 2008). This localization is critical for TORC1 function (Sancak 
et al., 2010; Zoncu et al., 2011). However, the mechanisms that 
localize TORC1 to the yeast vacuole and the mammalian lysosome 
are not known.
Some key regulators of TORC1 are also localized on the yeast 
vacuole and mammalian lysosome. These include the yeast EGO 
complex—in mammalian cells termed Ragulator (Dubouloz et al., 
2005; Gao and Kaiser, 2006; Binda et al., 2009; Kogan et al., 2010; 
Sancak et al., 2010)—and the mammalian lysosomal V-ATPase 
(Zoncu et al., 2011).
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yeast. Yeast mutants with defects in TORC1 activity are hypersensi-
tive to the TORC1 inhibitor rapamycin (Heitman et al., 1991; 
Loewith et al., 2002). Thus we tested growth on 1 ng/ml rapamycin, 
which is sublethal for wild-type yeast. Mutants with impaired TORC1 
function, tor1Δ and gtr1Δ, exhibit hypersensitivity to rapamycin 
(Figure 1A; Binda et al., 2009). Similarly, vac14Δ, vac7Δ, and fab1Δ 
mutants, which contain little or no detectable PI(3,5)P2, respectively 
(Bonangelino et al., 2002; Gary et al., 2002; Duex et al., 2006a), also 
exhibited hypersensitivity to rapamycin (Figure 1A). To further 
address the hypothesis that PI(3,5)P2 regulates TORC1 activity, 
we tested whether the hyperactive, dominant FAB1VLA mutant 
Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), a crucial, low-
abundance signaling phospholipid found in the endomembrane 
system, is generated from phosphatidylinositol 3-phosphate (PI3P) 
by the lipid kinase Fab1/PIKfyve (reviewed in Dove et al., 2009; 
McCartney et al., 2014). Fab1/PIKfyve is the sole enzyme that gen-
erates PI(3,5)P2 (Gary et al., 1998; Zolov et al., 2012). In yeast, Fab1 
is positively regulated by Vac7 (Bonangelino et al., 2002; Gary et al., 
2002), which has no known mammalian homologue. In addition, 
Fab1 activity requires the conserved scaffolding protein Vac14 
(Botelho et al., 2008; Jin et al., 2008; Sbrissa et al., 2008). PI(3,5)P2 
is converted to PI3P by the conserved lipid phosphatase Fig4 (Gary 
et al., 2002; Rudge et al., 2004), which paradoxically also serves as a 
positive regulator of Fab1 (Duex et al., 2006b).
Mutations predicted to cause only minor changes in PI(3,5)P2 
levels are associated with severe neurological diseases (Chow et al., 
2007, 2009). Moreover, loss of human Fig4 results in a multisystem 
congenital disorder that leads to infant mortality (Campeau et al., 
2013). Yet, despite its importance in human physiology, only a frac-
tion of the processes regulated by PI(3,5)P2 have been identified. 
Moreover, few proteins that bind directly to PI(3,5)P2 have been 
identified, and there are no known motifs that predict an interaction 
with PI(3,5)P2.
Recent studies revealed that the WD-40 domain of mammalian 
Raptor binds PI(3,5)P2 in vitro (Bridges et al., 2012), which raised the 
intriguing possibility that PI(3,5)P2 is an upstream regulator of 
TORC1. Consistent with this hypothesis, knockdown of PIKfyve, 
Vac14, or Fig4 in adipocytes resulted in a loss of the ability of insulin 
to stimulate TORC1 phosphorylation of S6 kinase (S6K). However, in 
these prior studies the conditions used to knock down Fig4 and 
Vac14 did not have a significant effect on PI(3,5)P2 levels, and knock-
down of PIKfyve had a modest effect. Thus how the short hairpin 
RNA experiments affected TORC1 function is unclear. Furthermore, 
in stimulated adipocytes, TORC1 was found at the plasma mem-
brane, raising questions about the subcellular location where PI(3,5)
P2 activates TORC1. In addition, the effect of PI(3,5)P2 on general 
pathways regulated by TORC1 was not assessed.
Here we report that PI(3,5)P2 is a positive regulator of TORC1 
activity on the yeast vacuole. We find that the TORC1 substrate 
Sch9, a yeast homologue of S6K, localizes on the vacuole via direct 
binding to PI(3,5)P2 and that this localization is required for TORC1-
dependent phosphorylation of Sch9. Moreover, we find that PI(3,5)
P2 regulates TORC1 phosphorylation of multiple targets and regu-
lates multiple TORC1 functions. We show that PI(3,5)P2 promotes 
nutrient-regulated endocytosis from the plasma membrane and in-
hibits autophagy via a requirement for PI(3,5)P2 in TORC1-depen-
dent phosphorylation of Npr1 and Atg13, respectively. Moreover, 
the requirement of PI(3,5)P2 in TORC1 inhibition of autophagy is 
exacerbated by a TORC1-independent role for PI(3,5)P2 in the deg-
radation of autophagic bodies. Thus, under nutrient-rich conditions, 
mutants with defects in PI(3,5)P2 carry a load of autophagic bodies 
in the vacuole. Together these findings show that PI(3,5)P2 is a con-
served upstream regulator of TORC1 and suggest that PI(3,5)P2 pro-
vides a platform for TORC1 signaling from the vacuole/lysosome. 
Moreover, these studies show that PI(3,5)P2 is a key regulator of 
cellular response to nutrient status via modulation of TORC1.
RESULTS
PI(3,5)P2 is required for TORC1 activity in vivo
Inhibition of PIKfyve causes a defect in insulin-dependent activation 
of mTORC1 in L1-3T3 adipocytes (Bridges et al., 2012). To deter-
mine whether PI(3,5)P2 is a conserved, general regulator of TORC1, 
we tested whether PI(3,5)P2 plays a role in TORC1 activation in 
FIGuRE 1: PI(3,5)P2 is required for TORC1 activity. (A) The fab1Δ, 
vac7Δ, and vac14Δ mutants are hypersensitive to rapamycin. The 
indicated strains were grown to mid log phase in YEPD medium and 
then diluted onto SC plates containing DMSO (control) or 1 ng/ml 
rapamycin, a sublethal dose for wild-type yeast. tor1Δ and gtr1Δ 
mutants have known defects in TORC1 function. Correlation between 
the ability to grow in the presence of 1 ng/ml rapamycin and 
intracellular PI(3,5)P2 levels was indicated by fab1Δ mutants, which 
have no detectable PI(3,5)P2, vac7Δ cells with very low levels of 
PI(3,5)P2, and vac14Δ cells with more PI(3,5)P2 than vac7Δ. 
(B) Increasing PI(3,5)P2 in vac7Δ or vac14Δ mutants restores TORC1 
activity. Sensitivity of vac7Δ or vac14Δ mutants to 1 ng/ml rapamycin 
is rescued by elevation of PI(3,5)P2 levels. Wild-type yeast and vac7Δ 
or vac14Δ mutants with plasmids expressing Fab1 or dominant active 
FAB1VLA were grown to mid log phase in SC-Ura medium and then 
diluted onto SC-Ura plates containing DMSO (control) or 1 ng/ml 
rapamycin.
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Rapamycin 1ng/ml DMSO
SC, 24°C, 3 days
SC-Ura, 24°C, 2 days
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Using fluorescence microscopy (Figure 2, A and B), as well as cell 
fractionation (Figure 2, C and D), we probed the effect of PI(3,5)P2 
on the localization of Tor1–3x green fluorescent protein (GFP) and 
Kog1-3xGFP. However, by cell fractionation, we did not detect large 
differences in the localization of Tor1-3xGFP or Kog1-3xGFP in the 
vac7∆ strain. Note that these tagged proteins were functional as 
measured by rapamycin sensitivity (Supplemental Figure S2, A and 
B). Similarly, the localization of Tor1-3xGFP(D330) and Kog1-3xGFP 
was largely unaffected by expression of the hyperactive FAB1VLA 
mutant (Supplemental Figure S2, C–G). In addition, the association 
of Kog1 with Tor1 was similar in wild type and the vac7Δ mutant 
(Supplemental Figure S2H). Nonetheless, we hypothesized that a 
small difference in localization of Kog1, and hence TORC1 to the 
vacuole, might result in a significant defect in TORC1 activity. Ac-
cordingly, we undertook a second approach to monitor the effect of 
PI(3,5)P2 on Kog1 localization.
We tested and found that artificially tethering Kog1 to the vacu-
ole partially suppresses the rapamycin hypersensitivity of the vac14Δ 
mutant. Vac8, a vacuolar membrane protein (Wang et al., 1998), 
does not require PI(3,5)P2 for its localization to the vacuole. Thus we 
used Vac8 as a PI(3,5)P2-independent tether. In contrast to Kog1-
GFP, which displayed some diffuse cytosolic staining pattern in the 
vac14∆ strain, we found that the Vac8-Kog1 fusion protein showed 
better colocalization on the vacuole membrane in the vac14Δ mu-
tant (Figure 2E). Vac8-Kog1 partially suppressed the rapamycin hy-
persensitivity of the vac14Δ mutant (Figure 2F). Note that the partial 
rescue by Vac8-Kog1 was not due to changes in the amount of 
Kog1, as the levels of the two proteins were similar at both 24 and 
37°C (Figure 2G). Similarly, although Kog1 was distributed between 
the pellet and supernatant fractions of cell lysates at 24 and 37°C, 
Vac8-Kog1 was found primarily in the P13 membrane fraction, which 
includes the vacuole (Figure 2G); the integral membrane proteins 
Vac7 and Vac8 were also localized to the P13 fraction. These data 
strongly support the hypothesis that at least one role of PI(3,5)P2 in 
TORC1 function occurs on the vacuole membrane. Furthermore, 
these data link the rapamycin hypersensitivity of the vac14Δ mutant 
to defects in both TORC1 localization and function.
The TORC1 substrate Sch9 localizes on the vacuole 
via PI(3,5)P2
To test for additional roles for PI(3,5)P2, we investigated whether 
PI(3,5)P2 recruits a subset of TORC1 substrates onto the vacuole 
membrane. Accordingly, we examined a well-characterized direct 
target of TORC1, Sch9, which is partially localized on the vacuole 
(Urban et al., 2007). Yeast Sch9 shares similar functions with mam-
malian S6 kinase, a downstream target and effector of mTORC1.
We first tested whether TORC1-dependent phosphorylation of 
Sch9 requires PI(3,5)P2. We used Sch9T570A, which contains five sites 
in its C-terminus that are directly phosphorylated by TORC1 and is 
missing a TORC1-independent phosphorylation site (Urban et al., 
2007). On 6% SDS–PAGE gel, Sch9T570A-HA5 migrates as multiple 
bands. The upper bands are due to phosphorylation; treatment with 
λ-phosphatase selectively removed the upper-migrating species 
(Supplemental Figure S3A). Examination of these proteins on 15% 
SDS–PAGE gel indicated that there was no apparent difference in 
stability of the phosphorylated versus nonphosphorylated forms of 
the protein (Supplemental Figure S3A).
Previous studies using a chemical fragmentation assay showed 
that phosphorylation of Sch9T570A-HA5 is dependent on TORC1 ac-
tivity, as measured by loss of phosphorylation in cells treated with 
rapamycin (Urban et al., 2007). Furthermore, phosphorylation of 
Sch9T570A-HA5 is virtually absent in a gtr1Δ mutant (Binda et al., 
suppressed the rapamycin hypersensitivity of the vac7Δ and vac14Δ 
mutants. Expression of an additional copy of Fab1 from a low-copy 
plasmid in the vac7Δ mutant had little effect on the levels of PI(3,5)
P2 (Duex et al., 2006b) or on the suppression of the sensitivity of 
vac7Δ to rapamycin (Figure 1B). In contrast, expression of the hyper-
active FAB1VLA mutant in vac7Δ or vac14Δ yeast, which raises the 
levels of PI(3,5)P2 above levels found in wild-type cells by ∼1.5- and 
3-fold, respectively (Duex et al., 2006b), suppressed the sensitivity 
of the vac7Δ and vac14Δ mutants to rapamycin (Figure 1B). This 
finding strongly suggests that PI(3,5)P2 levels rather than the Vac7 or 
Vac14 protein per se are required for TORC1 function. Moreover, in 
the vac7Δ mutant, whereas PI(3,5)P2 levels are deeply lowered, PI3P 
levels are twofold higher, yet this elevation in PI3P does not rescue 
TORC1 function; furthermore, both phosphatidylinositol 4-phos-
phate (PI4P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) 
levels are similar to wild-type levels (Gary et al., 2002). Similarly, in 
the vac14Δ mutant, only PI(3,5)P2 levels are lowered. In this mutant, 
PI3P levels are elevated above wild-type levels by 20%, whereas 
PI4P and PI(4,5P)2 levels are similar to wild-type levels (Dove et al., 
2002). Together these studies strongly suggest that PI(3,5)P2 modu-
lates TORC1 function.
PI(3,5)P2 activates TORC1 on the vacuole
Mammalian Raptor binds PI(3,5)P2, in vitro (Bridges et al., 2012), and 
thus we tested whether Kog1, the yeast homologue of Raptor, binds 
to PI(3,5)P2. A construct encoding glutathione S-transferase (GST) 
fused to amino acids 1162–1557 of Kog1, which contains the WD-
40 domain, was used for expression and purification of the protein 
from Escherichia coli. We found that Kog1(1162–1557) bound PI(3,5)
P2 with a dissociation constant of 19 ± 6 μM (Supplemental 
Figure S1). These data suggested the possibility that PI(3,5)P2 plays 
a role in the activation of TORC1 via its association with Kog1. Note 
that this affinity is substantially lower than that observed for Atg18, 
which exhibits a dissociation constant of <0.2 μM (Table 1; Dove 
et al., 2004). However, the affinity of Atg18 for PI(3,5)P2 is exception-
ally strong, likely due to two adjacent phosphoinositide-binding 
sites (Baskaran et al., 2012; Krick et al., 2012; Watanabe et al., 2012). 
Of importance, dissociation constants of 20 μM are commonly ob-
served in biologically significant interactions.
Phosphorylated phosphoinositide lipids often function by re-
cruiting downstream effectors to specific membrane subdomains. 
The translocation of mTORC1 onto the lysosome is important for 
mTORC1 activation under amino acid stimulation in mammalian 
cells (Sancak et al., 2010). This raised the possibility that PI(3,5)P2 
regulates yeast TORC1 function in part by recruiting TORC1, espe-
cially Kog1, to the vacuole or a subdomain on the vacuole.
Kd (μM) SEM (Kd) Rmax SEM (Rmax) R2
A. Kog1- and Sch9-binding affinity for PI(3,5)P2
Kog1 19 6 1627 206 0.8
Sch9 11 2 2743 154 0.96
B. Atg18-binding affinity for PI(3,5)P2
i 0.046 0.010 5053 332 0.8
ii 0.076 0.015 4341 217 0.89
Data are representative of three experiments. i, ii: SPR analysis of Atg18- and 
PI(3,5)P2-binding affinity performed alongside the Kog1 peptide (Figure 2) or 
Sch9 peptide (Figure 3), respectively.
TABLE 1: Surface plasmon resonance analysis of Kog1- or Sch9-
binding affinity for PI(3,5)P2.
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FIGuRE 2: PI(3,5)P2 is required for TORC1 activity on the vacuole, but TORC1 remains on the vacuole in mutants with 
low levels of PI(3,5)P2. (A) 3xGFP(D330)-Tor1 (green) and (B) Kog1-3xGFP (green) localizes on the vacuole membrane 
(red) in wild-type and vac7Δ mutant yeast. Vacuole membranes were visualized with FM 4-64. (C, D) In either the 
presence or absence of PI(3,5)P2, 3xGFP(D330)-Tor1 or Kog1-3xGFP is in the pellet (P) fraction, which includes vacuole 
membranes. Cell lysates of the indicated strains were centrifuged at 13,000 × g for 10 min at 4°C. Supernatant (S) 
fractions and whole-cell lysates (W) were suspended in the same volume of sample buffer, and pellet (P) fractions were 
suspended in twice the volume of sample buffer. Loading control for cell fractionation: Vac7 and Vac8, which tightly 
localize on the vacuole membrane. Red asterisk, Vac7 protein. (E) More Vac8-Kog1-GFP (green) localizes on the vacuole 
membrane (red, FM 4-64) than Kog1-GFP. Note that both Vac8-Kog1-GFP and Kog1-GFP are overexpressed, which 
likely accounts for the partial cytoplasmic localization of Kog1-GFP. (F) Expression of the Vac8-Kog1 fusion protein 
partially suppressed the rapamycin sensitivity of vac14Δ mutants at 37°C. The vac14Δ mutants with plasmids expressing 
empty vector (mock), Kog1, Vac8-Kog1, or Vac14 were grown to mid log phase in SC-URA medium and then diluted 
onto SC-URA plates containing DMSO (control) or 0.25 ng/ml rapamycin. Note that this level of rapamycin does not 
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We further tested and found that the N-terminal region of Sch9 
(amino acids [aa] 1–390) is sufficient for the localization of Sch9 on 
the vacuole in vivo. Full-length Sch9-GFP (1–824), as well as the C2 
domain–containing fragment, Sch9-GFP (1–390), localized on the 
vacuole membrane in the cytoplasm and the nucleus (Figure 3G). 
However, in the vac7Δ mutant with low levels of PI(3,5)P2, the local-
ization of Sch9-GFP (1–390) to the vacuole was defective (Figure 3G). 
Together these data strongly suggest that association of Sch9 with 
the vacuole requires PI(3,5)P2,and that the N-terminal region of Sch9 
contains the PI(3,5)P2-binding site.
PI(3,5)P2 is required for TORC1-dependent phosphorylation 
of Sch9 on the vacuole membrane
That Sch9 associates with the vacuole membrane via PI(3,5)P2 sug-
gests that PI(3,5)P2 serves as a platform for TORC1 and its target, 
Sch9. To address this hypothesis, we used an Sch9 C-terminal 
fragment (aa 709–824; cSch9), which contains all the TORC1 phos-
phorylation sites, S711, T723, S726, T737, S758, and S765 (Urban 
et al., 2007). We fused this fragment to either wild-type Vac8 or a 
mutant version, vac8-4; the vac8-4 protein is mutated at its myris-
toylation and palmitoylation sites (G2A, C4G, C5T, and C7S) and 
does not localize on the vacuole membrane (Wang et al., 1998). 
Accordingly, in wild-type yeast, Vac8-GFP-cSch9 localized on the 
vacuole membrane, whereas vac8-4–cSch9 was found in the cyto-
plasm (Figure 4A). Similarly, in a membrane fractionation assay, 
Vac8 and Vac8-cSch9 were distributed in the P13 and P100 mem-
brane fractions (Figure 4B). In contrast, a large amount of vac8-4–
cSch9 was also found in S13 and S100 cytosolic fractions 
(Figure 4B). Of note, Vac8-cSch9 but not vac8-4–cSch9 was phos-
phorylated by TORC1 (Figure 4C). These data suggest that the 
localization of Sch9 on the vacuole is required for its TORC1-de-
pendent phosphorylation.
To examine this further, we expressed Vac8-cSch9 or vac8-4-
cSch9 in a vac7Δ mutant. Similar to the wild-type strain, in the vac7Δ 
mutant, Vac8-cSch9 localized on the vacuole, but vac8-4-cSch9 was 
diffuse in the cytoplasm (Figure 4A). Of importance, Vac8-cSch9 was 
phosphorylated by TORC1 in the vac7Δ mutant (Figure 4C). These 
data suggest that PI(3,5)P2-dependent localization of Sch9 on the 
vacuole is required for its phosphorylation by TORC1. Together 
these findings strongly support the hypothesis that PI(3,5)P2 is criti-
cal for the localization Sch9 on the vacuole, where it is phosphory-
lated by TORC1.
Of note, when compared side by side, the degree of TORC1-
dependent phosphorylation of Vac8-cSch9 in the vac7Δ mutant was 
less than in a wild-type strain (Figure 4C, rightmost panel). This sug-
gests that in addition to localization of the TORC1 target, PI(3,5)P2 on 
the vacuole has further roles in the positive regulation of TORC1.
PI(3,5)P2 is required for TORC1 phosphorylation 
of multiple substrates
TORC1 functions in multiple pathways via phosphorylation of its tar-
gets and regulates cell growth. Because yeast mutants with defects 
in PI(3,5)P2 have pleiotropic defects, we tested whether PI(3,5)P2 is 
required for multiple TORC1-dependent pathways via regulation of 
TORC1 phosphorylation of additional targets.
2009). Consistent with these studies, the gel shift assay also indi-
cated that phosphorylation of Sch9T570A-HA5 was blocked by addi-
tion of rapamycin and required the presence of Gtr1 (Supplemental 
Figure S3A). Of note, Sch9T570A-HA5 was significantly less phospho-
rylated in the fab1Δ and vac7Δ mutants (Figure 3A). These findings 
demonstrate that mutants that do not maintain normal levels of 
PI(3,5)P2 are defective in TORC1-dependent phosphorylation of 
Sch9.
To extend our analysis, we examined the complementary situa-
tion, using the FAB1VLA mutant to generate elevated PI(3,5)P2. We 
found that concomitant with suppression of rapamycin sensitivity 
(Figure 1B), expression of the hyperactive mutant in vac7Δ or vac14Δ 
yeast resulted in increased phosphorylation of Sch9T570A-HA5 
(Figure 3B; see 6% gel). In contrast, expression of an additional one 
or two copies of wild-type Fab1 had little effect on Sch9 phosphory-
lation in the vac7∆ strain and showed partial suppression in vac14∆ 
cells, in agreement with lack of suppression of rapamycin sensitivity. 
In addition, the degree of FAB1VLA-dependent phosphorylation of 
Sch9T570A-HA5 was lower in vac7Δ compared with the vac14Δ mu-
tant. This parallels the levels of PI(3,5)P2, which are lower in the for-
mer mutant compared with the latter (Duex et al., 2006a). Together 
these observations provide strong support for the hypothesis that 
PI(3,5)P2 is required for TORC1-dependent phosphorylation of 
Sch9.
In wild-type yeast, Sch9 is found both on the vacuole membrane 
and in the cytoplasm (Urban et al., 2007; Figure 3C). Thus we tested 
whether PI(3,5)P2 is required for Sch9 recruitment to the vacuole. 
Note that the localization of GFP-Sch9 to the vacuole did not re-
quire active TORC1 (Figure 3C); GFP-Sch9 localization in a gtr1Δ 
mutant was similar to that observed in the wild-type strain. However, 
the vacuolar localization of GFP-Sch9 was compromised in a vac7Δ 
mutant. Moreover, elevation of PI(3,5)P2 in the vac7Δ mutant by ex-
pression of hyperactive FAB1VLA restored the localization of Sch9 to 
the vacuole membrane (Figure 3D and Supplemental Figure S3, B 
and C). These findings show that PI(3,5)P2 recruits the TORC1 sub-
strate Sch9 to the vacuole and further suggest that Sch9 might di-
rectly bind this lipid.
To test this hypothesis, we generated a GST fusion protein of the 
first 400 amino acids of Sch9, which includes a C2 domain (Figure 3E). 
C2 domains often bind specific phosphoinositide lipids (Lemmon, 
2008). The Sch9 C2 domain–containing peptide bound PI(3,5)P2 
with a dissociation constant of 11 ± 2 μM (Figure 3, E and F, and 
Table 1). It is possible that Sch9 associates with other phosphoinosit-
ide lipids in vivo, including PI3P, which is also synthesized on endo-
somes. However, PI3P cannot recruit Sch9 in vivo: PI3P levels in a 
wild-type strain are 30-fold higher than PI(3,5)P2 levels (Duex et al., 
2006a), and in the vac7Δ mutant, the levels of PI3P are twofold 
higher than levels in a wild-type strain (Gary et al., 2002). Yet despite 
this high level of PI3P, Sch9 is not recruited to the vacuole. In addi-
tion, PI4P and PII4,5)P2 are not responsible for the recruitment of 
Sch9: in wild-type cells, PI4P and PI(4,5)P2 levels are ∼20-fold higher 
than that of PI(3,5)P2, and in the vac7Δ mutant the levels of PI4P and 
PI(4,5P2) remain unchanged (Gary et al., 2002). Together these data 
indicate that the association of Sch9 with the vacuole requires PI(3,5)
P2 and that PI3P, PI4P, and PI(4,5)P2 cannot substitute for PI(3,5)P2.
interfere with growth of the vac14Δ mutant at 24°C for 7 d. (G) In the vac14Δ mutant, Vac8-Kog1 cofractionates with the 
P13 fraction at either 24 or 37°C (30 min), which includes the vacuole. Cell lysates were centrifuged at 13,000 × g for 
10 min at 4°C. Supernatant (S) fractions and whole-cell lysates (W) were resuspended in the same volume of sample 
buffer, and the pellet (P) fractions were resuspended in twice the volume of sample buffer. Loading controls for cellular 
fractionation: Vac7 and Vac8, which tightly localize on the vacuole membrane. Red asterisk, Vac7 protein.
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FIGuRE 3: PI(3,5)P2 is required for the localization of Sch9 on the vacuole. (A) Phosphatase treatment indicates that 
phosphorylation of Sch9-T570A-HA can be assayed by altered mobility on 6% SDS–PAGE. Lysates from 5 × 106 cells 
from a wild-type strain transformed with a plasmid expressing Sch9-T570A-HA5 were incubated at 30°C for 1 h with (+) 
or without (–) 6000 U of λ-phosphatase (New England Biolabs, Ipswich, MA). As assessed by mobility on 6% SDS–PAGE, 
the degree of TORC1-dependent phosphorylation of Sch9-T570A-HA5 is greatly diminished in the gtr1Δ mutant. The 
degree of TORC1-dependent phosphorylation of Sch9-T570A-HA5 is also greatly diminished in fab1Δ and vac7Δ 
mutants. (B) TORC1-dependent phosphorylation of Sch9-T570A-HA5 in vac7Δ and vac14Δ mutants is rescued by 
elevation of PI(3,5)P2 levels. TORC1-dependent phosphorylation of Sch9-T570A-HA5 assessed by mobility on 6% 
SDS–PAGE in wild-type, vac7Δ, or vac14Δ cells with a vector control or plasmids expressing Fab1 or FAB1VLA. In A and 
B, loading controls were Sch9-T570A-HA5 and Pgk1 run on 15% SDS–PAGE. (C) GFP-Sch9 (green) partially colocalizes 
with the vacuole membrane (red) in wild-type and gtr1Δ yeast but not in the vac7Δ mutant. Vacuole membranes were 
visualized with FM 4-64. (D) Increasing PI(3,5)P2 restores the localization of GFP-Sch9 in vac7Δ mutants. Mock or 
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lation of Atg13 is required to inhibit autophagy in nutrient-rich con-
ditions. Moreover, TORC1-dependent activity of Sch9 also contrib-
utes to the inhibition of autophagy, independent of phosphorylation 
of Atg13 (Yorimitsu et al., 2007). Our findings that less PI(3,5)P2 
caused defects in TORC1 phosphorylation of Atg13 and Sch9 led us 
to test whether lower levels of PI(3,5)P2 also resulted in a corre-
sponding induction of autophagy under nutrient-rich conditions.
The autophagy pathway involves the sequestration of cytoplasm 
and/or organelles into autophagosomes, which fuse with the vacu-
ole/lysosome. The breakdown of proteins and membranes in the 
vacuole provides new building blocks and energy for cellular reno-
vation and homeostasis. We tested whether PI(3,5)P2 inhibits au-
tophagy, using two common assays that monitor Atg8 behavior.
Atg8 is required for both autophagy and the cytoplasm-to-
vacuole targeting (Cvt) pathway (Kirisako et al., 1999; Huang et al., 
2000). Atg8 localizes on autophagosomes via its conjugation with 
phosphatidylethanolamine (Mizushima et al., 1998). Atg8 on the 
inner membrane of the autophagosome is delivered to the vacu-
ole and is degraded there (Kim et al., 2001). In the case of GFP-
Atg8, the GFP moiety is resistant to degradation and accumulates 
in the vacuole lumen. Thus production of free GFP from GFP-Atg8 
can be used to monitor autophagy and the Cvt pathway either by 
microscopy or via Western blot analysis by probing for released 
GFP.
We expressed GFP-Atg8 in wild type or the vac7Δ mutant and 
quantified the induction of autophagy by microscopy. Wild-type 
yeast cells contained only single GFP-Atg8–positive puncta near the 
vacuole membrane under normal conditions, and the population of 
cells containing GFP puncta was <20% (Figure 6, A and B). In addi-
tion, there was no detectable fluorescence signal within the vacuole 
lumen. On induction of autophagy using rapamycin treatment, GFP-
Atg8 was targeted to the vacuole, free GFP was released, and the 
entire vacuole lumen was filled with GFP (Figure 6A). During ra-
pamycin treatment, the population of cells with GFP puncta or GFP-
filled vacuoles increased to >90% (Figure 6B). In contrast, in the 
vac7Δ mutant, GFP puncta accumulated in the vacuole lumen even 
under basal conditions, and the population of cells with GFP puncta 
was >70% (Figure 6, A and B). Note that the GFP-Atg8 in the vacu-
ole lumen of vac7∆ cells was present as puncta compared with the 
diffuse distribution seen in the lumen of wild-type cells. Of impor-
tance, the GFP puncta in the vacuole lumen were a result of the in-
appropriate induction of autophagy under nutrient-rich conditions. 
Atg1 plays a key role in the initiation and continuation of autophagy. 
When an atg1Δ mutant was treated with rapamycin, GFP-Atg8 was 
not transported to the vacuole lumen because autophagy was 
blocked (Supplemental Figure S4, A and B; Cheong et al., 2008). 
Similarly, in a vac7Δ atg1Δ double mutant, whereas GFP-Atg8–pos-
itive puncta were observed in the cytoplasm near the vacuole mem-
brane, these were not delivered to the vacuole either in basal condi-
tions or during rapamycin treatment (Figure 6, C and D, and 
Supplemental Figure S4).
Under nutrient-rich conditions, active TORC1 is required for in-
hibitory hyperphosphorylation of Npr1 (Schmidt et al., 1998), which 
allows ubiquitin-mediated endocytosis of selected plasma mem-
brane transporters and their delivery for degradation in the vacuole 
(MacGurn et al., 2012). Of note, in the vac7Δ mutant, Npr1 was less 
phosphorylated than in a wild-type strain, and inhibition of TORC1 
with rapamycin caused similar loss of phosphorylation of Npr1 in 
both strains (Figure 5A).
TORC1-dependent phosphorylation of Npr1 releases its inhibi-
tory block on the endocytosis of Can1, an arginine permease 
(MacGurn et al., 2012). Canavanine is a toxic analogue of arginine. 
Thus, under nutrient-rich conditions, mutants that do not have nor-
mal inhibition of Npr1 have excess Can1 on the plasma membrane 
and are hypersensitive to canavanine (Lin et al., 2008). The finding 
that less PI(3,5)P2 resulted in a defect in TORC1-dependent phos-
phorylation of Npr1 prompted us to test whether PI(3,5)P2 is required 
for TORC1-regulated inhibition of Npr1 to release its block on the 
endocytosis of Can1. We therefore analyzed canavanine sensitivity in 
vac7Δ and fab1Δ mutants. The tor1Δ mutant, as well as the vac7Δ 
and fab1Δ mutants, were hypersensitive to canavanine (Figure 5B). 
vac14Δ, which is less defective in PI(3,5)P2 levels, was less sensitive 
than the vac7Δ mutant. To test further whether this defect was due 
to low levels of PI(3,5)P2, we expressed the hyperactive FAB1VLA mu-
tant in the vac7Δ mutant and analyzed canavanine sensitivity. The 
increase in levels of PI(3,5)P2 by FAB1VLA suppressed the sensitivity 
to canavanine in the vac7Δ mutant (Figure 5C). These data suggest 
that transport of Can1 from the plasma membrane via TORC1-de-
pendent inhibitory phosphorylation of Npr1 requires PI(3,5)P2.
It is not known whether Npr1 is a direct target of TORC1. Thus, 
in addition to the direct target Sch9, we chose to examine Atg13, 
another well-characterized direct target of TORC1. Atg13 functions 
in the initiation of autophagy (Kamada et al., 2010). Starvation or 
treatment of cells with rapamycin induces autophagy via inhibition 
of TORC1-inhibitory phosphorylation of Atg13.
We analyzed the degree of phosphorylation of Atg13 using mu-
tants that have low levels of PI(3,5)P2. Atg13 is highly phosphory-
lated by TORC1 (Kamada et al., 2010), and this phosphorylation is 
largely reversed by treatment with rapamycin or phosphatase 
(Figure 5D). In the gtr1∆ mutant with reduced TORC1 activity, Atg13 
phosphorylation was decreased. Similarly, in vac14Δ or vac7Δ mu-
tants with reduced levels of PI(3,5)P2, Atg13 was less phosphory-
lated (Figure 5D).
Together these data suggest that PI(3,5)P2 is required for TORC1-
dependent phosphorylation of multiple substrates and furthermore 
that through positive regulation of TORC1, PI(3,5)P2 regulates sev-
eral pathways, including autophagy and nutrient-regulated endocy-
tosis of Can1.
Autophagy is negatively regulated by PI(3,5)P2
A previous study suggested that PI(3,5)P2 does not play a role in 
autophagy in yeast (Dove et al., 2004). However TORC1 phosphory-
FAB1VLA plasmids were expressed in wild-type or vac7Δ cells. Analysis of degree of colocalization of GFP-Sch9 and FM 
4-64 is shown in Supplemental Figure S3, B and C. (E) Schematic of Sch9 indicating the peptide (aa 1–400) tested for 
binding to PI(3,5)P2, the predicted calcium/lipid-binding C2 domain (aa 182–356), and the kinase domain (aa 400–824). 
(F) Recombinant GST-Sch9 fusion protein was tested for its ability to bind PI(3,5)P2, using surface plasmon resonance. 
The peptide including the C2 domain of Sch9 binds PI(3,5)P2 with a dissociation constant of 11 ± 2 μM (Table 1). 
Equilibrium-state response levels (RU) for each protein concentration were assessed. Data from three independent 
experiments. (G) GFP fused to the N-terminal fragment of Sch9 (aa 1–390) localizes on the vacuole in wild-type cells but 
not in vac7Δ mutants. Vacuole membranes were visualized with FM 4-64. In wild-type or vac7Δ mutants, GFP fused to 
the full length (aa 1–824), N-terminus fragment (aa 1–390), or C-terminus fragment (aa 391–824) of Sch9 (green) was 
overexpressed. Vacuole membranes were visualized with FM 4-64.
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FIGuRE 4: PI(3,5)P2 is required for TORC1-dependent phosphorylation of Sch9 on the vacuole. (A) Vac8, but not vac8-4, 
fused to the C-terminal fragment of Sch9 (aa 709–824: cSch9) localizes on the vacuole in both wild-type cells and vac7Δ 
mutants. Vacuole membranes were visualized with FM 4-64. (B) In wild-type yeast, Vac8-cSch9 cofractionates with the 
P13 and P100 fractions, which include the vacuole. However, a large amount of vac8-4–cSch9 cofractionates with the 
S100, which corresponds to the cytosolic fraction. Cell lysates were centrifuged at 13,000 × g for 10 min at 4°C. 
Supernatant (S13) fractions and whole-cell lysates (W) were resuspended in the same volume of sample buffer, and the 
pellet (P13) fraction was resuspended in twice the volume of sample buffer. Then, S13 fractions were centrifuged at 
100,000 × g for 30 min at 4°C. Supernatant (S100) fractions were resuspended in the same volume of sample buffer, and 
the pellet (P100) was resuspended in twice the volume of sample buffer. Loading controls for cellular fractionation were 
Vac7 and Vac8, which tightly localize on the vacuole membrane. Red asterisk, Vac7 protein. (C) Localization of cSh9 on 
the vacuole via PI(3,5)P2 is required for its TORC1-dependent phosphorylation. TORC1-dependent phosphorylation of 
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To further address whether PI(3,5)P2 is required for the inhibition 
of autophagy in nutrient-rich conditions, we expressed the hyperac-
tive FAB1VLA mutant in vac7Δ cells and quantified the induction of 
autophagy by microscopy. Increasing the levels of PI(3,5)P2 by the 
FAB1VLA mutant or by expression of wild-type VAC7 suppressed the 
accumulation of GFP puncta in the vacuole under basal conditions 
(Supplemental Figure S4C) and restored the number of cells without 
GFP puncta to wild-types levels in basal conditions (Figure 6E). 
However, expression of Fab1 from a low-copy plasmid did not re-
store PI(3,5)P2 levels or suppress the inappropriate induction of au-
tophagy under nutrient-rich conditions. Together these data sug-
gest that PI(3,5)P2 is required for inhibition of autophagy under basal 
conditions.
In an independent test, we performed Western blot analysis for 
free GFP using whole yeast lysates from the cultures visualized in 
Figure 6. In the vac7Δ mutant the degradation of GFP-Atg8 was in-
hibited under both nutrient-rich conditions and rapamycin treat-
ment (Supplemental Figure S4D), consistent with the presence of 
GFP puncta in the vacuole lumen in the vac7Δ mutant. The presence 
of GFP puncta in the vacuole suggested that autophagosomes are 
transported into the vacuole but not degraded, resulting in accumu-
lation of autophagic bodies. Consistent with this hypothesis, in-
creasing the levels of PI(3,5)P2 by expressing the FAB1VLA mutant in 
the vac7Δ strain resulted in correct degradation of GFP-Atg8 in the 
vacuole lumen during the induction of autophagy (Figure 6F).
The yeast vacuole is a weakly acidic compartment that contains 
a wide variety of hydrolases that are only active in this acidic envi-
ronment. Furthermore, the pH gradient across the vacuole mem-
brane establishes an electrochemical potential that is needed for 
the transport of various metabolites, including calcium and phos-
phate ions, establishing a unique milieu that is needed for optimal 
hydrolase activity. Accordingly, proper acidification is required for 
the degradation of autophagic bodies in the vacuole lumen but not 
FIGuRE 5: TORC1-dependent regulation of multiple pathways 
requires PI(3,5)P2. (A) Phosphorylation of Npr1-HA3 is greatly 
diminished in vac7Δ mutants. Wild-type or vac7Δ strains that express 
Npr1-HA3 were grown on YEPD; then rapamycin was added to a final 
concentration of 200 ng/ml. Cells were incubated for an additional 
30 min. The degree of phosphorylation of Npr1 was assessed by 
migration during 6% SDS–PAGE. Loading control: Pgk1 run on 15% 
SDS–PAGE. (B) The tor1Δ, fab1Δ, and vac7Δ mutants with defects in 
TORC1 function are hypersensitive to canavanine. The indicated 
strains were grown to mid log phase in YEPD medium and then 
diluted onto SC-Arg plates in the presence or absence of 2 μg/ml 
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Vac8-cSch9 or vac8-4-cSch9 assessed by mobility on 7% SDS–PAGE. Wild-type or vac7Δ yeast, with a plasmid 
expressing Vac8-cSch9-HA5 or vac8-4-cSch9-HA5, was grown in SC-His medium, and then a final concentration of 
200 ng/ml rapamycin (+) was added to the cell culture. Cells were incubated for an additional 1 h. Lysates from 5 × 106 
cells with or without rapamycin treatment were incubated at 30°C for 1 h with (+) or without (–) 6000 U λ-phosphatase 
(New England Biolabs). As assessed by mobility on 7% SDS–PAGE, the degree of TORC1-dependent phosphorylation of 
Vac8-cSch9-HA5 was greatly diminished in both wild-type and vac7Δ mutant yeast with rapamycin treatment. Loading 
controls were Vac8- or vac8-4–cSch9-HA5 and Pgk1 run on 15% SDS–PAGE. Right, subset of analyses from left and 
middle repeated to allow side-by-side comparison of wild-type and vac7Δ strains. Of note, there was less 
phosphorylation of Vac8-cSch9 in vac7Δ than with a wild-type strain. This provides additional support for the hypothesis 
that PI(3,5)P2 plays additional roles beyond recruitment of Sch9.
canavanine, a sublethal dose for wild-type yeast. (C) Sensitivity of 
vac7Δ mutants to 1 μg/ml canavanine is rescued by elevation of 
PI(3,5)P2 levels. Wild-type cells with empty vector or the vac7Δ 
mutant with plasmids expressing mock, Fab1, or FAB1VLA were 
grown to mid log phase in SC-Ura medium and then diluted onto 
SC-Arg-Ura plates in the presence or absence of 1 μg/ml canavanine. 
(D) Phosphorylation of HA3-Atg13 is greatly diminished in vac14Δ, 
vac7Δ, fab1Δ, and gtr1Δ mutants. Wild-type, vac14Δ, vac7Δ, fab1Δ, or 
gtr1Δ strains with a plasmid expressing HA3-Atg13 were grown in 
SC-Leu medium, and then either a final concentration of 200 ng/ml 
rapamycin (+) or DMSO alone (–) was added to the cell culture. 
Cells were incubated for an additional 2 h. Lysates from 5 × 106 cells 
from each strain were incubated at 30°C for 1 h with (+) or without (–) 
6000 U of l-phosphatase (New England Biolabs). The degree of 
phosphorylation of Atg13 was assessed by migration in 6% SDS–
PAGE. Loading control: Pgk1 run on 15% SDS–PAGE.
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FIGuRE 6: PI(3,5)P2 regulates autophagy. PI(3,5)P2 is required both for inhibition of autophagy during vegetative 
growth and degradation of autophagic bodies. (A) Wild-type or vac7Δ strains with a plasmid expressing GFP-Atg8 were 
grown in SC-Ura medium. Rapamycin at a final concentration of 200 ng/ml was added, and cells were incubated for an 
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The precise mechanisms for PI(3,5)P2-dependent TORC1 activa-
tion remain to be determined. In yeast, TORC1 localizes on the 
vacuole with or without amino acid stimulation (Sturgill et al., 2008; 
Binda et al., 2009). In contrast, mTORC1 translocates onto the lyso-
some specifically during amino acid stimulation (Sancak et al., 2010). 
The simple postulate that PI(3,5)P2 acts solely via recruitment of 
TORC1 to endosomes is unlikely because artificial recruitment of 
TORC1 to the vacuole in the absence of PI(3,5)P2 only partially re-
stores TORC1 function (Figure 2). Our findings, as well as others, 
suggest three ways that PI(3,5)P2 may play roles in the activation of 
TORC1.
First, amino acids play a major role in the regulation of TORC1. 
Thus PI(3,5)P2 may be involved in sensing amino acids. The vacuole/
lysosome is a major reservoir for amino acids (Messenguy et al., 
1980), which are released as needed during vegetative growth. In 
mammals, amino acids stored in the lysosome are detected by the 
lysosomal V-ATPase, which in turn activates TORC1 (Zoncu et al., 
2011). Of note, yeast mutants with defects in PI(3,5)P2 have less-
acidified vacuoles and may have defects in V-ATPase activity 
(Bonangelino et al., 2002). Thus PI(3,5)P2 may indirectly activate 
TORC1 via direct activation of the V-ATPase. However, this is unlikely 
to be the sole role of PI(3,5)P2 in TORC1 function. Both Kog1 and 
Sch9 interact directly with PI(3,5)P2. Moreover, PI(3,5)P2 is required to 
recruit Sch9 to the vacuole, where it is phosphorylated by TORC1.
Second, PI(3,5)P2 may directly activate TORC1. The essential 
TORC1 subunit Raptor functions as a scaffold for the TORC1 com-
plex (Hara et al., 2002; Kim et al., 2002; Nojima et al., 2003; Sancak 
et al., 2008; Yip et al., 2010), and yeast Kog1 likely serves similar 
roles. Of note, Kog1 (Supplemental Figure S1) and its mammalian 
homologue, Raptor (Bridges et al., 2012), directly bind PI(3,5)P2 in 
vitro. Thus PI(3,5)P2 may activate TORC1 through direct interaction 
with Kog1/Raptor, which may modulate the structure of TORC1. 
However, integrity of the TORC1 complex does not appear to be 
grossly affected by loss of PI(3,5)P2; Kog1 interaction with Tor1 still 
occurs in a vac7Δ mutant (Supplemental Figure S2).
Third, a membrane subdomain that includes PI(3,5)P2 may exist 
on the vacuole and serve as a platform for TORC1, its substrates, 
and regulators, including the EGO complex. Recruitment of the 
TORC1 substrate Sch9 to the vacuole requires PI(3,5)P2. Moreover, 
in a global study, Ego3, a component of the EGO complex, was 
shown to bind phosphorylated phosphatidylinositol lipids (Zhu 
et al., 2001).
TORC1-dependent phosphorylation occurs on vacuole/
lysosome membranes
That PI(3,5)P2-dependent localization of Sch9 on the vacuole is re-
quired for TORC1-dependent phosphorylation of Sch9 (Figures 3 
for the formation or delivery of autophagosomes to the vacuole 
(Nakamura et al., 1997). Of importance, mutants with low or no 
PI(3,5)P2 do not have fully acidified vacuoles (Bonangelino et al., 
1997, 2002; Dove et al., 2002). Together our studies indicate that 
the inhibition of autophagy by TORC1 is defective in mutants with 
low levels of PI(3,5)P2. In addition, we found that PI(3,5)P2 is required 
for the completion of autophagy. In the absence of PI(3,5)P2, au-
tophagic bodies are not degraded in the vacuole lumen. Thus 
PI(3,5)P2 negatively regulates the induction of autophagy via posi-
tive regulation of TORC1 activity and positively functions in the 
resolution of autophagy through the degradation of autophagic 
bodies.
DISCUSSION
The endosomal membrane lipid PI(3,5)P2 regulates multiple path-
ways. Pleiotropic defects observed in yeast, mice, and cultured cells 
caused by deficiencies in PI(3,5)P2 strongly suggest that many of the 
pathways regulated by PI(3,5)P2 have not yet been identified. More-
over, these pleiotropic phenotypes make it difficult to determine 
which individual pathways are directly regulated by this lipid. Identi-
fication of effector proteins provides a means to reveal processes 
that are directly modulated by PI(3,5)P2. Here we show that PI(3,5)P2 
regulation of TORC1 is required for at least three TORC1-depen-
dent pathways. Specifically, we show that 1) PI(3,5)P2 is required for 
the activation of TORC1 on the vacuole membrane; 2) a major sub-
strate of TORC1, Sch9, associates with the vacuole membrane via 
PI(3,5)P2, and this association is required for TORC1-dependent 
phosphorylation of Sch9; and 3) PI(3,5)P2 plays a key role in addi-
tional TORC1-regulated pathways, including nutrient-dependent 
endocytosis of Can1 and inhibition of autophagy, via TORC1-de-
pendent phosphorylation of Npr1 and Atg13, respectively. These 
studies expand our knowledge of pathways regulated by PI(3,5)P2 
and show that via modulation of TORC1 function, PI(3,5)P2 is a key 
regulator of cellular response to nutrient status.
Regulation of TORC1 by PI(3,5)P2 on endosomal 
compartments
Despite the importance of PI(3,5)P2 for modulation of TORC1, it is 
likely that PI(3,5)P2 is necessary but not sufficient for TORC1 activa-
tion. Note that hyperosmotic stress results in a 20-fold elevation of 
PI(3,5)P2 (Duex et al., 2006a), yet this same treatment inhibits 
TORC1 phosphorylation of Sch9 (Urban et al., 2007). The inhibi-
tion of TORC1 during hyperosmotic stress occurs via as-yet-un-
identified upstream regulators. This divergence in the effects of 
hyperosmotic shock on PI(3,5)P2 and TORC1 is consistent with the 
postulate that PI(3,5)P2 is not the sole upstream regulator of 
TORC1 function.
additional 2 h. Vacuole membranes were visualized with FM 4-64. (B) Quantification of cells with GFP-Atg8 puncta or 
vacuoles filled with GFP or GFP-Atg8 from A. Three independent trials with >100 cells counted/trial. Error bars in B 
represent SD of triplicate experiments. (C, D) vac7Δ or atg1Δ vac7Δ strains with a plasmid expressing GFP-Atg8 was 
grown in SC-Ura medium. Rapamycin at a final concentration of 200 ng/ml was added, and cells were incubated for an 
additional 2 h. Vacuole membranes were visualized with FM 4-64. (C) Quantification of cells with vacuoles filled with GFP 
or GFP-Atg8 from D. The data represent three independent trials with >100 cells counted/trial. Error bars in C represent 
SD of triplicate experiments. (E). Quantification of the number of cells with Atg8 puncta or vacuoles filled with GFP or 
GFP-Atg8. Wild-type or vac7Δ strain with plasmids expressing GFP-Atg8 and mock, Vac7, Fab1, or FAB1VLA was grown 
in SC-Ura-Trp medium, and then a final concentration of 200 ng/ml rapamycin was added and cells were incubated for 
an additional 2 h. The data are an average from two trials with >100 cells/trial. (F) Increasing PI(3,5)P2 by expression of 
the FAB1VLA mutant restores the defect in the degradation of GFP-Atg8. Wild-type or vac7Δ strain with plasmids 
expressing GFP-Atg8 and mock, Vac7, or FAB1VLA was grown in SC-Ura-Trp, and then a final concentration of 200 ng/ml 
rapamycin was added. Cells were incubated for an additional 4 h. Western blot was performed using anti-GFP antibody. 
Loading control: Pgk1.
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and 4) makes it tempting to speculate that 
TORC1 phosphorylation of multiple targets 
may require their recruitment to the vacu-
ole/lysosome by PI(3,5)P2. In mammals, S6K 
and eIF4E-binding protein 1 (Brunn et al., 
1997; Hara et al., 1997; Burnett et al., 1998; 
Isotani et al., 1999), the transcription factor 
EB (TFEB; Settembre et al., 2012), lipin-1 
(Peterson et al., 2011), and Atg13 and 
Ulk1 (Hosokawa et al., 2009), and in yeast, 
Sch9, Atg13 (Kamada et al., 2010), Sfp1 
(Lempiainen et al., 2009), and Gln3 (Bertram 
et al., 2000), are direct targets of TORC1. 
With the exception of TFEB and Sch9, the 
location where these targets are phosphory-
lated by TORC1 is not known. mTORC1-
dependent phosphorylation of TFEB occurs 
on the lysosome and regulates the translo-
cation of TFEB to the nucleus during lyso-
somal stress or amino acid stimulation (Pena-
Llopis and Brugarolas, 2011; Settembre 
et al., 2012). The activation of Rag GTPase 
by the V-ATPase (Settembre et al., 2012) 
and the association of active Rags with TFEB 
(Martina and Puertollano, 2013) are required 
for translocation of TFEB to the lysosome. 
Whether PI(3,5)P2 is required for TORC1 
phosphorylation of TFEB or other targets 
has not been tested. Perhaps TFEB or other 
substrates, including S6K, target to the lyso-
some/vacuole membrane via PI(3,5)P2 and 
are thereby brought to TORC1 via PI(3,5)P2 
signaling (Figure 7).
Roles for PI(3,5)P2 in autophagy
Atg13 is a direct target of TORC1 and is hy-
perphosphorylated under nutrient-rich con-
ditions, which inhibits autophagy (Kamada 
et al., 2010). Although it had been reported 
that in yeast PI(3,5)P2 is not involved au-
tophagy (Dove et al., 2004), we found that 
PI(3,5)P2 is required for TORC1-dependent 
inhibition of autophagy (Figures 6 and Sup-
plemental Figure S4) via TORC1 phosphory-
lation of Atg13 (Figure 5D). These findings 
make it tempting to speculate that Atg13 is 
an effector of PI(3,5)P2. Atg13, as well as ad-
ditional proteins, play key roles in the initia-
tion of autophagy and, as part of the initia-
tion, are recruited to the phagophore 
assembly site (reviewed in Nakatogawa 
et al., 2009). PI(3,5)P2 may be required for 
recruitment of Atg13 to the phagophore as-
sembly site via TORC1-dependent phos-
phorylation of Atg13.
That PI(3,5)P2 is required for TORC1 inhi-
bition of autophagy raises the possibility 
that Atg18, which plays a role in the forma-
tion of autophagosomes (Obara et al., 2008; 
Nair et al., 2010), may also serve a second 
role in autophagy. Atg18, independent of its 
role in forming autophagosomes, is a nega-
tive regulator of PI(3,5)P2 synthesis (Dove 
FIGuRE 7: PI(3,5)P2 is a critical upstream regulator of TORC1. (A) PI(3,5)P2-dependent activation 
of TORC1 and recruitment of substrates to the vacuole membrane. Kog1, a subunit of TORC1, 
and the TORC1 substrate, Sch9, are downstream effectors of PI(3,5)P2. PI(3,5)P2 recruits Sch9 
and likely additional TORC1 targets to the vacuole, where their TORC1-dependent 
phosphorylation occurs. (B) PI(3,5)P2 is required for TORC1-dependent phosphorylation of 
multiple substrates and TORC1-dependent inhibition of autophagy, as well as regulation of 
nutrient-dependent endocytosis. TORC1-dependent phosphorylation of each substrate tested, 
Sch9, Npr1, and Atg13, requires PI(3,5)P2, which suggests that phosphorylation of these 
substrates occurs on the vacuole. In addition, PI(3,5)P2-mediated TORC1-dependent 
phosphorylation of Npr1 or Atg13 is required to release Npr1-dependent inhibition of Can1 
endocytosis and TORC1-dependent inhibition of autophagy, respectively. Note that in addition 
to regulation of TORC1, PI(3,5)P2 modulates pathways that are independent of TORC1 signaling.
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Rapamycin sensitivity
Cells were grown as indicated in YEPD or selective media to mid log 
phase. Cells were collected and resuspended in media, and 10-fold 
serial dilutions from 0.1 OD/ml were performed. Cells were trans-
ferred to YEPD or selective media plates containing dimethyl sulfox-
ide (DMSO; control) and the indicated concentrations of rapamycin. 
Cells were incubated at 24°C for 2–7 d or 37°C for 2–7 d. Images 
were obtained every day starting at day 2.
Protein purification
Proteins were expressed in E. coli BL21 star (DE3) pRARE. Cells were 
grown in Luria broth with 0.05 mg/ml ampicillin and 0.025 mg/ml 
spectinomycin at 37°C to an OD600 of 0.3. After 18 h of induction 
with 0.2 mM isopropyl-β-d-thiogalactoside at 16°C, cells were har-
vested. Cells were sonicated in lysis buffer (20 mM Tris-HCl, pH 7.4, 
200 mM NaCl, 1 mM dithiothreitol [DTT]). Proteins were purified 
with glutathione Sepharose resin (GE Healthcare, Little Chalfont, 
Buckinghamshire, England), concentrated by spin filtration using 
an Ultrafree-4 centrifugal filter 50K or 30K membrane (Millipore, 
Darmstadt, Germany), and dialyzed in Biacore buffer (25 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.4, 150 mM 
NaCl, 1 mM DTT).
Western blot
Log-phase cells were lysed (Duex et al., 2006b), and the lysates 
separated by SDS–PAGE and transferred to nitrocellulose. Antibody 
dilutions were anti-Pgk1 (Invitrogen, Grand Island, NY), 1:10,000; 
anti-hemagglutinin (Covance, Princeton, NJ), 1:3000; and anti-GFP 
(Roche, Basel, Switzerland), 1:500.
Surface plasmon resonance analysis
Surface plasmon resonance analysis was performed as described 
previously (Dove et al., 2004; Narayan and Lemmon, 2006). GST-
Atg18 (PI(3,5)P2) served as a positive control (Dove et al., 2004), 
and GST was a negative control. Proteins were used within 24 h of 
cell lysis, and lipid surfaces were used within 8 h of generation. 
Affinity was measured using sensor surfaces containing di-oleyl-
phosphatidylcholine liposomes doped with PI(3,5)P2 at a molar 
ratio of 97:3. In an initial experiment, no binding was detected 
between GST-Sch9 or GST-Kog1 and the PI(3,5)P2 surface. To in-
crease sensitivity, the molar ratio of PI(3,5)P2 was increased to 
22:3. Binding was measured by flowing protein samples over the 
sensor surface. Lipids (Eschelon) were bound to sensor chips, 
L1 (Biacore, GE Healthcare). Four sensors were available for each 
run. The first and second sensors contained only phosphatidylcho-
line (PC). The subsequent two sensors contained PC:PI(3,5)P2. Two 
sensors were dedicated to PC:PI(3,5)P2 in order to obtain more 
accurate binding constants. Phosphoinositides:PC were present at 
a molar ratio of 22:3. Response to PC alone was subtracted from 
the responses detected from the phosphoinositide-containing 
chips. Binding data are presented at the indicated protein concen-
tration injected. The Kd values and maximum binding (Rmax) were 
calculated by using Prism (GraphPad). Data were fitted to the 
equation
)(= + +Y B X K X/ backgrounddmax
where Y is total binding, X is the protein concentration, Bmax is 
the maximum specific binding in the same units as Y, and Kd is 
the equilibrium binding constant in the same units as X. Back-
ground is the amount of nonspecific binding with no added 
protein.
et al., 2004). Through two adjacent sites, Atg18 tightly binds both 
PI3P and PI(3,5)P2 (Dove et al., 2004; Baskaran et al., 2012; Krick 
et al., 2012; Watanabe et al., 2012). These lipid-binding sites on 
Atg18 are required for Atg18 localization on the vacuole, both for 
the autophagy pathway (Obara et al., 2008; Nair et al., 2010) and for 
negative regulation of the synthesis of PI(3,5)P2 (Dove et al., 2004; 
Efe et al., 2007). Perhaps via inhibition of PI(3,5)P2 synthesis, Atg18 
promotes the inhibition of TORC1 and the subsequent activation of 
autophagy.
PI(3,5)P2 also plays a TORC1-independent role in autophagy. 
The absence of PI(3,5)P2 causes defects in the degradation of au-
tophagic bodies (Figure 6 and Supplemental Figure S4), which are 
likely due to defects in the acidification of the vacuole (Bonangelino 
et al., 1997, 2002; Nakamura et al., 1997). These findings show that 
there are both TORC1-dependent and TORC1-independent roles 
for PI(3,5)P2 in autophagy. Moreover, in the absence of PI(3,5)P2, the 
induction of autophagy during nutrient-rich conditions is likely fur-
ther exacerbated by PI(3,5)P2-related defects in the degradation of 
autophagic bodies.
These roles for PI(3,5)P2 in the inhibition of autophagy and the 
resolution of autophagic bodies are likely conserved. Autophagy 
is important for neural function and neonatal survival in mice 
(Kuma et al., 2004; Hara et al., 2006; Efeyan et al., 2013). Similarly, 
mice deficient in the synthesis of PI(3,5)P2 show defects in the ner-
vous system and early lethality (Zhang et al., 2007; Zolov et al., 
2012). These similarities are consistent with a link between PI(3,5)
P2 and autophagy in all metazoans. Indeed, defects in Fab1/
PIKfyve function cause autophagic dysfunction in mammals 
(Jefferies et al., 2008; de Lartigue et al., 2009; Ferguson et al., 
2009; Martin et al., 2013), Caenorhabditis elegans (Nicot et al., 
2006), and Drosophila (Rusten et al., 2007). Similar to yeast, de-
fects in PI(3,5)P2 production in mammalian cells result in the loss of 
nutrient-dependent inhibition of autophagy (Jefferies et al., 2008; 
Martin et al., 2013). Thus the requirement for PI(3,5)P2-dependent 
activation of TORC1 for inhibition of autophagy is likely conserved. 
The TORC1-dependent and independent roles for PI(3,5)P2 de-
scribed here join a growing list of pathways modulated by PI(3,5)
P2. The pleiotropic defects in yeast, cultured mammalian cells, and 
mice predict that PI(3,5)P2 likely has multiple additional roles in 
endosomal physiology.
MATERIALS AND METHODS
Strains and media
Yeast strains and plasmids are listed in the Supplemental Experi-
mental Procedures. Yeast were grown in yeast extract/peptone/
dextrose (YEPD) or synthetic minimal medium without selective 
amino acid(s) at 24°C. Construction of plasmids and strains is de-
scribed in the Supplemental Experimental Procedures.
Generation of functional Tor1-3xGFP and Kog1-3xGFP
To generate functional Tor1-3xGFP, we expressed Tor1 with inter-
nally integrated 3xGFP at amino acid D330, a site that does not 
impair Tor1 localization or function (Sturgill et al., 2008). This con-
struct was expressed as the sole copy of TOR1 from the TOR1 en-
dogenous locus. For Kog1, the 3xGFP tag was placed at the C-ter-
minus of Kog1. Kog1-3xGFP was expressed as the sole copy of 
KOG1 from the endogenous locus.
Fluorescence microscopy
Mid–log phase cells were labeled with FM 4-64 (Vida and Emr, 
1995). Images were acquired using the DeltaVision RT Restoration 
Microscopy System (Applied Precision, Issaquah, WA).
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